Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-28 @ 7:37 PM
Study NCT ID:
NCT00685204
Status:
UNKNOWN
Last Update Posted:
2008-05-28
First Post:
2008-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
Sponsor:
Taxolog Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TL139204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Harvey Pass, M.D. Chief, Division of Thoracic Surgery and Thoracic Oncology
Old Organization:
New York University Cancer Center